Recent clinical evidence supported an expanded role for xanthine oxidase (XO) pathway in the pathogenesis of HF, as up-regulated activity of XO and increased reactive oxygen species (ROS) might lead to oxidative stress, endothelial dysfunction, vascular inflammation, etc, having detrimental effects on HF. This evidence concerns the gene XDH and endothelial dysfunction.